Evaluation of the Efficacy and Safety Between Two Antiretroviral Regimens, in HIV-1-infected Treatment-naïve Subjects With Low CD4 Counts

Conditions

• HIV-1 Infection
• Immunosuppression-related Infectious Disease

Interventions

• DRUG: DARUNAVIR
• DRUG: ATAZANAVIR

Sponsor

Institut de Médecine et d'Epidémiologie Appliquée - Fondation Internationale Léon M'Ba